Buy this biopharmaceutical stock that can rally 25%, says RBC Capital Markets found 2025 › Feb › 25 (Tue) @ 12:56 UTC a story from CNBC › Top News RBC Capital Markets ■ preview The firm initiated coverage at an outperform rating.